NCT00536107 2013-10-01Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)AstraZenecaPhase 4 Terminated14 enrolled 12 charts